Shares of Ascletis Pharma , the first biotech firm to list in Hong Kong under the new rules, are trading about 66% below is IPO price, while performances of the rest are mixed. …
( read original story …)
The HongKong News
Shares of Ascletis Pharma , the first biotech firm to list in Hong Kong under the new rules, are trading about 66% below is IPO price, while performances of the rest are mixed. …
( read original story …)